Macrolide Antibiotics
The macrolide class includes erythromycin, azithromycin, and clarithromycin as the three primary drugs available in North America, with azithromycin technically classified as an azalide (a closely related 15-membered ring compound). 1
Core Macrolide Medications
14-Membered Ring Macrolides
- Erythromycin - the first macrolide antibiotic, launched commercially in 1952, remains the least expensive but is less commonly used due to gastrointestinal intolerance and lack of activity against H. influenzae 1
- Clarithromycin - a newer 14-membered macrolide with improved tolerability and broader spectrum than erythromycin 1
- Roxithromycin - another 14-membered macrolide available in some countries 1, 2
15-Membered Ring Macrolides (Azalides)
- Azithromycin - technically an azalide (closely related to macrolides), became available in the 1980s with superior activity against H. influenzae and improved pharmacokinetics allowing once-daily dosing 1
Additional Macrolides
Mechanism of Action
All macrolides share a common mechanism: they reversibly bind to the 23S rRNA component of the 50S bacterial ribosomal subunit, specifically at the polypeptide exit region, thereby inhibiting RNA-dependent protein synthesis. 1, 2 While generally bacteriostatic, macrolides demonstrate bactericidal activity against autolytic species such as pneumococci. 1
Key Structural Features
Macrolides are defined by their macrocyclic lactone ring containing 12 or more elements, with the most commonly used antibiotics having either 14-membered rings (erythromycin, clarithromycin) or 15-membered rings (azithromycin). 1, 4
Clinical Considerations
The CDC recommends macrolides (erythromycin, clarithromycin, or azithromycin) as preferred agents for treatment of pertussis in persons aged >1 month, with azithromycin specifically preferred for infants <1 month. 1 For community-acquired pneumonia, macrolides are recommended as monotherapy for previously healthy outpatients or in combination with β-lactams for hospitalized patients. 1
Important Distinctions
- Lincomycin is NOT a macrolide - it belongs to the lincosamide class, which is structurally different despite sharing the same ribosomal binding site and cross-resistance patterns with macrolides 4
- Telithromycin - represents a newer ketolide class (modified 14-membered macrolides with a 3-keto group replacing the L-cladinose moiety), though it has limited use due to safety concerns 5, 6